Formulation and evaluation of compression coated tablets for controlled release of cefadroxil monohydrate
Mahantesh P. Paruti1, Vijaykumar V. Alange1, Srinivas Mutalik2, Akram A. Naikawadi3 and Raghavendra V. Kulkarni1*
1Department of Pharmaceutical Technology, BLDEA’s College of Pharmacy, BLDE University Campus, Bijapur, Karnataka, India
2Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal, Karnataka, India
3Department of Pharmacology, Shri. B.M. Patil Medical College, BLDE University, Bijapur 586 103, Karnataka, India
*Corresponding Author E-mail: rvkulkarni75@yahoo.com
ABSTRACT:
In the present study, an attempt was made to prepare and evaluate the natural polymers based compression coated tablets for controlled release of an antibiotic, cefadroxil monohydrate. The core tablets were prepared by direct compression method and compression coating granules were prepared by wet granulation method using sodium alginate and xanthan gum. The weight and drug content of all the tablets were found to be uniform. The hardness and friability were found within specified range. The core tablets released 99% drug within 1 h, while the compression coated tablets were capable of releasing the drug for 24 h. The coating formula containing more amount of aluminum chloride released the drug slowly as compared to barium chloride. Drug release mechanism was found to be non-Fickian transport type.
KEYWORDS: Compression coated tablets, cefadroxil monohydrate, controlled release, sodium alginate, xanthan gum.
INTRODUCTION:
Oral route of drug administration is the most widely used route of administration among all the routes that have been explored for systemic delivery of drugs via pharmaceutical products of different dosage form1,2. The oral route is considered most natural, uncomplicated, convenient and safe due to its ease of administration, patient acceptance, and cost-effective manufacturing process3,4. The pharmaceutical products designed for oral delivery are mainly immediate release type or conventional drug delivery systems, which are designed for immediate release of drug for rapid absorption5,6. These immediate release dosage forms have some limitations. In order to overcome the drawbacks of conventional drug delivery systems, several technical advancements have led to the development of controlled drug delivery system that could revolutionize method of medication and provide a number of therapeutic benefits7-9.
The controlled release systems have made significant progress in terms of clinical efficacy and patient compliance10 and they have many advantages like, improved efficacy, reduced toxicity and improved patient compliance and convenience11.
Controlled release is beneficial for drugs that are rapidly metabolized and eliminated from the body after administration. In recent years, hydrophilic matrices of natural polymers have been very popular for controlling the release of drugs from solid dosage forms. These are attractive approaches from an economic as well as process development point of view. The oral controlled-release formulations containing inert matrices release their drugs through either diffusion and/or dissolution-controlled mechanism12.
Cefadroxil is an important first generation semi-synthetic cephalosporin. It is a broad spectrum antibiotic, effectively used against various infections caused by gram positive and gram negative bacteria. Because of its poor aqueous solubility and short elimination half life of 1.5 to 2 h, it requires multiple dosing to achieve and maintain therapeutic levels13.
Table 1. Formula for core tablets
|
Sl. No. |
Ingredients (mg) |
Quantity (mg) |
|
1 |
Cefadroxil monohydrate |
200 |
|
2 |
Lactose |
11 |
|
3 |
Sodium starch glycolate |
30 |
|
4 |
Talc |
6 |
|
5 |
Magnesium stearate |
3 |
Table 2. Formulae for coating material
|
Codes |
Composition of tablets (mg) |
||||||
|
SA |
XG |
AlCl3 |
BaCl2 |
Lactose |
Talc |
Magnesium stearate |
|
|
SXC 1 |
150 |
-- |
50 |
-- |
35 |
10 |
5 |
|
SXC 2 |
150 |
-- |
75 |
-- |
10 |
10 |
5 |
|
SXC 3 |
150 |
-- |
-- |
50 |
35 |
10 |
5 |
|
SXC 4 |
150 |
-- |
-- |
75 |
10 |
10 |
5 |
|
SXC 5 |
100 |
50 |
75 |
-- |
10 |
10 |
5 |
|
SXC 6 |
100 |
50 |
-- |
75 |
10 |
10 |
5 |
|
SXC 7 |
75 |
75 |
75 |
-- |
10 |
10 |
5 |
|
SXC 8 |
75 |
75 |
-- |
75 |
10 |
10 |
5 |
|
SXC 9 |
150 |
-- |
25 |
25 |
35 |
10 |
5 |
SA: Sodium alginate, XG: Xanthan gum, AlCl3: Aluminium chloride, BaCl2: Barium chloride.
This suggests that cefadroxil is a suitable candidate for the development of oral controlled release system, which avoids the need of repeated administration and thus improves the patient compliance. The present work is aimed at the development of compression coated tablets for controlled release of cefadroxil monohydrate using natural polymers such as sodium alginate (SA) and xanthan gum (XG).
MATERIALS AND METHODS:
Materials
Cefadroxil monohydrate was obtained as gift sample from Elegant Pvt. Ltd. Hubli (India). Sodium alginate (SA) and xanthun gum (XG) were purchased from S.D fine Chemicals, Mumbai (India). Aluminum chloride (AlCl3) and barium chloride (BaCl2) were purchased from Qualegens chemicals, Mumbai (India) and Sodium starch glycolate (SSG) was obtained as gift sample from Kemwell Pvt. Ltd. Bangalore (India). Double distilled water was used throughout the experiments. All other chemicals were of analytical grade.
Preparation of compression coated tablets
Core tablets
The core tablets (average weight 250 mg) were prepared by direct compression technique. A weighed quantity of drug, lactose, sodium starch glycolate, talc and magnesium stearates were thoroughly mixed within a mortar and pestle and passed through the mesh (# 80) to ensure complete mixing. The powder weighing 250 mg was taken and compressed into tablets using 8 mm round, flat and plain punches. The composition of core tablets is given in Table 1.
Compression coated tablets
The formulated core tablets were compression-coated with the different granular coatings of SA and XG in different ratios with a coat weight of 250 mg. The granules required for coating of core tablets were prepared by wet granulation method. For compression coating, about 50% of granular material was first placed in the die cavity. Then, the core tablet was carefully positioned at the centre manually, which was then filled with the remaining 50% of granular material. The coating material was then compressed around the core tablet by using 12 mm round, flat and plain punches. The composition of compression-coat granular material is shown in Table 2. The granules were evaluated for bulk density, tapped density, packing ability and flow property.
Evaluation of tablets
Drug content uniformity
Ten tablets were randomly selects and allowed to equilibrate with 7.4 pH phosphate buffer solution overnight. The solution was filtered (0.22 μ membrane, Millipore) and absorbance of the solution was noted using UV-Visible spectrophotometer at 230 nm using after appropriate dilutions with 7.4 pH phosphate buffer. The concentration of drug in the solution was calculated by using the calibration curve of drug prepared in 7.4 pH phosphate buffer at 230 nm.
In-vitro drug release studies
In vitro drug release study was carried out using a USP-23 rotating dissolution tester. The dissolution study of the tablets was carried out at 37.0±0.50 C and 50 rpm speed in 900 ml acidic medium (pH 1.2) for first 2 h and then in alkaline medium (pH 7.4 phosphate buffer) till end of the study. At predetermined time intervals, 5 ml aliquots were withdrawn and replaced with the same volume of fresh solution. The amount of drug released was analyzed using UV-Visible Spectrophotometer at 230 nm. The release data were fitted into various mathematical models (zero order release kinetics, Higuchi model and Korsmeyer-Peppas model) to know which model is best fitting for the obtained drug release profile.
Apart from above tests, the tablets were evaluated for routine weight variation, hardness and friability tests.
RESULTS AND DISCUSSION:
The natural polymer based compression coated tablets containing sodium alginate and xanthan gum as polymers were prepared for controlled release of cefadroxil monohydrate. A total of nine formulations were prepared and evaluated (Figure 1).
Core Tablet
Compression coat
Figure 1. Photograph of compression coated tablets showing inner core and outer compression coating before dissolution.
Table 3. Evaluation of compression coating granules
Tablets |
Bulk density (mg/ml) |
Tapped density (mg/ml) |
Carr’s Index (%) |
Hausner’s ratio |
Angle of repose (O) |
SXC1 |
0.43 |
0.53 |
23.256 |
1.233 |
27.32 |
SXC2 |
0.41 |
0.56 |
36.585 |
1.366 |
30.23 |
SXC3 |
0.48 |
0.54 |
12.500 |
1.125 |
29.65 |
SXC4 |
0.43 |
0.57 |
32.558 |
1.326 |
28.65 |
SXC5 |
0.48 |
0.53 |
10.417 |
1.104 |
29.78 |
SXC6 |
0.49 |
0.5 |
2.041 |
1.020 |
30.53 |
SXC7 |
0.4 |
0.52 |
30.000 |
1.300 |
26.75 |
SXC8 |
0.44 |
0.6 |
36.364 |
1.364 |
28.95 |
SXC9 |
0.41 |
0.61 |
48.780 |
1.488 |
26.42 |
All the values are average of three determinations.
|
Tablets |
Weight (mg) |
Hardness (kg/cm2) |
Friability (%) |
Drug Content (%) |
SXC1 |
515 |
5.2 |
0.32 |
96.56 |
SXC2 |
506 |
5.3 |
0.35 |
98.43 |
SXC3 |
521 |
5.5 |
0.39 |
94.15 |
SXC4 |
513 |
5.1 |
0.48 |
95.49 |
SXC5 |
506 |
5.8 |
0.89 |
96.96 |
SXC6 |
498 |
5.9 |
0.91 |
97.90 |
SXC7 |
499 |
5.1 |
0.62 |
99.24 |
SXC8 |
496 |
5.6 |
0.47 |
93.88 |
SXC9 |
504 |
5.5 |
0.81 |
95.08 |
All the values are average of three determinations.
Table 5. Kinetic values of cefadroxil release from compression coated tablets
|
Tablets |
Zero order Equation |
Higuchi Equation |
Korsmeyer-Peppas Equation |
|||
|
n |
r |
n |
r |
n |
r |
|
SXC1 |
5.336 |
0.972 |
27.30 |
0.996 |
0.589 |
0.99 |
SXC2 |
4.331 |
0.980 |
23.68 |
0.982 |
0.598 |
0.998 |
SXC3 |
4.293 |
0.970 |
24.62 |
0.988 |
0.573 |
0.983 |
SXC4 |
5.860 |
0.970 |
20.42 |
0.991 |
0.586 |
0.986 |
SXC5 |
5.248 |
0.957 |
21.52 |
0.981 |
0.578 |
0.995 |
SXC6 |
5.320 |
0.962 |
22.57 |
0.999 |
0.567 |
0.995 |
SXC7 |
4.852 |
0.972 |
23.56 |
0.987 |
0.556 |
0.992 |
SXC8 |
5.321 |
0.962 |
24.85 |
0.985 |
0.523 |
0.986 |
SXC9 |
5.841 |
0.932 |
21.85 |
0.996 |
0.513 |
0.987 |
r: Correlation coefficients, n: Slope
Figure 2. Drug release profiles of compression coated tablets containing cefadroxil monohydrate
The results of evaluation of granules (Table 3) suggest that all the granules exhibit good flow properties as the angle of repose values were less than 30o. A good packing ability of the granules was indicated by Carr’s compressibility index and Hausner’s ratio. The results of post-compression evaluations are given in Table 4. The average weight and drug content determinations of all the tablets were found to be uniform with low SD values. The drug content was found in the range of 93.88 to 99.24%. The hardness was in the range of 5.1 to 5.9 kg/cm2 and friability was in the range of 0.32 to 0.91%.
The dissolution profiles of the tablets of are given in Figure 2 and kinetic data are presented in Table 5. The results indicated that the core tablets showed complete dissolution within 1 h; whereas the compression coated tablets extended to the drug release up to 24 h. A lag time of 1 to 2 h was observed for all the compression coated tablets. The presence of aluminum chloride in the coating formula resulted in slow release of drug as compared to barium chloride. As the concentrations of aluminum chloride and barium chloride were increased, the drug release was decreased. The results also indicated that the drug release was increased as the concentration of xanthan gum was increased. Overall, SXC2 formulation with highest aluminum chloride released the drug more slowly and 78.83% drug was released from this tablet at the end of 24 h. On the other hand, SXC8 formulation released 95.58% of drug at the end of 24 h. Korsmeyer-Peppas equation was finally employed to conclude the drug release mechanism. The calculated n values along with the correlation coefficients are shown in Table 5. The values of n depended upon the amount of aluminum chloride, barium chloride and xanthan gum concentrations. The calculated n values suggested that the mechanism of drug release followed non-Fickian transport.
CONCLUSIONS:
It can be concluded from the present study that, the compression coated tablets were found to exhibit controlled release of drug up to 24 h. Though 1-2 h of lag time was observed with compression coated tablets, later the drug release was extended for 24 h depending upon the formulations. Therefore, the compression coated tablets of sodium alginate and xanthan gum containing aluminum chloride are suitable for oral controlled release of cefadroxil monohydrate. Although the present study showed promising in vitro results, preclinical in vivo studies have to be carried out to confirm the results of present study.
ACKNOWLEDGEMENTS:
Authors are thankful to the Vision Group on Science and Technology, Government of Karnataka, India for the financial support. Authors are also thankful to Dr. B. G. Mulimani, Vice Chancellor, BLDE University and the management of BLDE Association, Bijapur for providing the facilities to carry out this work.
REFERENCES:
1) Varma MVS, Kaushal AM, Garg A and Garg S. 2004 “Factors affecting mechanism and kinetics of drug release from matrix based oral controlled drug delivery systems”. Am. J. Drug Deliv. 2: 43-57.
2) Hiroshi S., Yasuhiko M., Toshio O., Masahru M., Hisakazu S. 1997 “Dissolution mechanism of diclofenac sodium from wax matrix granules”. J. Pharm. Sci, 86: 929-935.
3) Silvina A., Bravo R., Claudio J. 2002 “In vitro studies of diclofenac sodium controlled from biopolymeric hydrophilic matrices”. J. Pharm. Pharmaceut. Sci, 5: 213-219.
4) Vidyadhar S., Ramarao P., Prasad J.A. 2004 “Formulation and evaluation of propranolol hydrochloride oral controlled release matrix tablets”. Ind. J. Phar. Sci, 66: 188-192.
5) Kim J.E., Kim S.R., Lee S.H., Lee C.H., Kim D.D. 2000 “The effect of pore formers on the controlled release of cefadroxil from a polyurethane matrix”. Int. J. Pharm. 201: 29-36.
6) Panchagnula R., Gupta A., Kandavilli S., Varma M. V. S. 2006 “High-throughput evaluation of non-swellable controlled release matrix tablets”. Drug Dev.Ind. Pharm. 32: 669-675.
7) Mohammad Nezab Uddin, Ishtiaq Ahmed, Monzurul Amin Roni, Muhammad Rashedul Islam, Mohammad Habibur Rahman and Reza-ul Jalil , 2009. “ In vitro Release Kinetics Study of Ranolazine from Swellable Hydrophilic Matrix Tablets” Dhaka Univ. J. Pharm. Sci. 8(1): 31-38
8) Hindustan Abdul Ahad, Chitta Suresh Kumar, Kishore Kumar Reddy B, Ravindra BV, Sasidhar CGS, Abhilash C, Sagar NRV . 2010. “Designing and Evaluation of Diclofenac Sodium Sustained Release Matrix Tablets Using Hibiscus Rosa-Sinensis Leaves Mucilage”. Int. J. Pharm. Scie.Review and Research, 1:29-31.
9) Santanu Ghosh and B. B. Barik, 2009. “Preparation and evaluation of aceclofenac sustained release formulation and comparison of formulated and marketed product” Int. J. Medicine and Med. Scie. 1: 375-382.
10) Mohammad Safiqul Isla, Selim Reza, and Habibur Rahman, 2008. “In vitro Release Kinetics Study of Diltiazem Hydrochloride from Wax and Kollidon SR Based Matrix Tablets”. Iranian J. Pharm. Res. 7: 101-108.
11) Chen J., Blevins W.E., Park H., Park K. 2000 “Gastric retention properties of superporous hydrogels”. J. Control. Rel, 64: 39-51.
12) Schnurch A.B., Guggi D., Pinter Y. 2004 “Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system”. J. Control. Release, 94: 177-186.
13) Kulkarni A.R., Soppimath K.S., Aminabhavi T.M., Rudzinski W.E. 2001 “In-vitro release kinetics of cefadroxil-loaded sodium alginate interpenetrating network beads”. Eur. J. Pharm. Biopharm. 51:127-133.
Received on 12.02.2013 Modified on 28.02.2013
Accepted on 10.03.2013 © RJPT All right reserved
Research J. Pharm. and Tech. 6(4): April 2013; Page 356-359